Gossamer Bio, Inc. (GOSS) NASDAQ
0.44
-0.0229(-4.98%)
Currency In USD
- General
- Statistics
- Historical Data
- Profile
- Financials
0.44
-0.0229(-4.98%)
Currency In USD
| Market Cap | 204.65M |
| Enterprise Value | 361.45M |
| P/E Ratio | -0.64 |
| PEG Ratio | 0.06 |
| Price/Sales Ratio | 2.3 |
| Price/Book Ratio | -1.21 |
| Enterprise/Revenue | 6.7 |
| Enterprise/EBITDA | -2.02 |
| Fiscal Year | December 31, 2024 |
| Most Recent Quarter | September 30, 2025 |
| Profit Margin | -3.55 |
| Operating Margin | -3.65 |
| Return On Assets | -0.75 |
| Return On Equity | 5.94 |
| Revenue | 114.7M |
| Revenue/Share | 0.19 |
| Gross Profit | 114.7M |
| EBITDA | -39.97M |
| Net Income | -56.53M |
| Diluted EPS | -0.25 |
| Total Cash | 180.22M |
| Total Cash/Share | 0.79 |
| Total Debt | 202.88M |
| Total Debt/Equity | -2.46 |
| Current Ratio | 3.28 |
| Book Value Per Share | -0.36 |
| 52-Week Change | -69.86 |
| 52-Week High | 3.87 |
| 52-Week Low | 0.33 |
| Moving Average 50 Days | 1.89 |
| Moving Average 200 Days | 2.22 |
| Average Volume | 14.19M |
| Shares Outstanding | 231.46M |
| % Held by Institutions | 81.14 |
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | N/A |
| Last Split Date | N/A |